Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1966 1
1968 3
1969 5
1970 5
1971 3
1972 3
1973 6
1974 3
1975 3
1976 7
1977 2
1979 3
1980 7
1981 4
1982 7
1983 6
1984 7
1985 3
1986 3
1987 6
1988 7
1989 18
1990 21
1991 19
1992 33
1993 25
1994 31
1995 30
1996 38
1997 35
1998 58
1999 48
2000 36
2001 50
2002 52
2003 73
2004 51
2005 47
2006 54
2007 46
2008 41
2009 61
2010 45
2011 60
2012 57
2013 85
2014 81
2015 69
2016 68
2017 80
2018 66
2019 50
2020 73
2021 67
2022 87
2023 77
2024 35

Text availability

Article attribute

Article type

Publication date

Search Results

1,849 results

Results by year

Filters applied: . Clear all
Page 1
Hemolytic-Uremic Syndrome in Children.
Boyer O, Niaudet P. Boyer O, et al. Pediatr Clin North Am. 2022 Dec;69(6):1181-1197. doi: 10.1016/j.pcl.2022.07.006. Epub 2022 Oct 29. Pediatr Clin North Am. 2022. PMID: 36880929 Review.
Hemolytic uremic syndrome is characterized by a triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney failure. Most cases are caused by Shiga-toxin-producing bacteria, especially Escherichia coli. ...
Hemolytic uremic syndrome is characterized by a triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney failur …
An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura.
Joly BS, Coppo P, Veyradier A. Joly BS, et al. Expert Rev Hematol. 2019 Jun;12(6):383-395. doi: 10.1080/17474086.2019.1611423. Epub 2019 May 20. Expert Rev Hematol. 2019. PMID: 31107120 Review.
Introduction: Thrombotic thrombocytopenic purpura (TTP) is a rare and life-threatening thrombotic microangiopathy characterized by microangiopathic hemolytic anemia, consumption thrombocytopenia, and organ injury. TTP pathophysiology is based on a severe ADAMTS13 deficienc …
Introduction: Thrombotic thrombocytopenic purpura (TTP) is a rare and life-threatening thrombotic microangiopathy characterized by microangi …
Platelet transfusion in adults: An update.
Garraud O, Hamzeh-Cognasse H, Chalayer E, Duchez AC, Tardy B, Oriol P, Haddad A, Guyotat D, Cognasse F. Garraud O, et al. Transfus Clin Biol. 2023 Feb;30(1):147-165. doi: 10.1016/j.tracli.2022.08.147. Epub 2022 Aug 27. Transfus Clin Biol. 2023. PMID: 36031180 Free article. Review.
PC transfusions are essential for the treatment of central thrombocytopenia of diverse causes, and such treatment is beneficial in patients at risk of severe bleeding. PC transfusions account for almost 10% of all the blood components supplied by blood services, but they a …
PC transfusions are essential for the treatment of central thrombocytopenia of diverse causes, and such treatment is beneficial in pa …
Treatment of drug-induced immune thrombocytopenias.
Marini I, Uzun G, Jamal K, Bakchoul T. Marini I, et al. Haematologica. 2022 Jun 1;107(6):1264-1277. doi: 10.3324/haematol.2021.279484. Haematologica. 2022. PMID: 35642486 Free PMC article. Review.
Several therapeutic agents can cause thrombocytopenia by either immune-mediated or non-immune-mediated mechanisms. Non-immune-mediated thrombocytopenia is due to direct toxicity of drug molecules to platelets or megakaryocytes. Immune-mediated thrombocytopenia …
Several therapeutic agents can cause thrombocytopenia by either immune-mediated or non-immune-mediated mechanisms. Non-immune-mediate …
Thrombocytopenia in chronic liver disease.
Peck-Radosavljevic M. Peck-Radosavljevic M. Liver Int. 2017 Jun;37(6):778-793. doi: 10.1111/liv.13317. Epub 2016 Dec 27. Liver Int. 2017. PMID: 27860293 Review.
Thrombocytopenia is a common haematological disorder in patients with chronic liver disease. ...As a result of the increased risk of bleeding, thrombocytopenia may impact upon medical procedures, such as surgery or liver biopsy. The pathophysiology of thrombocyto …
Thrombocytopenia is a common haematological disorder in patients with chronic liver disease. ...As a result of the increased risk of …
The role of platelets in bleeding in patients with thrombocytopenia and hematological disease.
Vinholt PJ. Vinholt PJ. Clin Chem Lab Med. 2019 Nov 26;57(12):1808-1817. doi: 10.1515/cclm-2019-0380. Clin Chem Lab Med. 2019. PMID: 31465290 Free article. Review.
For patients with leukemia and immune thrombocytopenia, reduced platelet activation, platelet aggregation, or thrombopoiesis, reflected by the reduced presence of reticulated platelets, are associated with bleeding phenotype. ...Promising tools for platelet function studie …
For patients with leukemia and immune thrombocytopenia, reduced platelet activation, platelet aggregation, or thrombopoiesis, reflect …
VEXAS syndrome: Clinical, hematologic features and a practical approach to diagnosis and management.
Koster MJ, Lasho TL, Olteanu H, Reichard KK, Mangaonkar A, Warrington KJ, Patnaik MM. Koster MJ, et al. Am J Hematol. 2024 Feb;99(2):284-299. doi: 10.1002/ajh.27156. Epub 2023 Nov 11. Am J Hematol. 2024. PMID: 37950858 Review.
While hematologic parameters may be generally non-specific, peripheral blood features of macrocytosis, monocytopenia, and/or thrombocytopenia coupled with bone marrow vacuolization of erythroid or myeloid precursors should raise suspicion for this condition. ...Treatment o …
While hematologic parameters may be generally non-specific, peripheral blood features of macrocytosis, monocytopenia, and/or thrombocytop …
Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.
López-Briz E, Ruiz Garcia V, Cabello JB, Bort-Martí S, Carbonell Sanchis R. López-Briz E, et al. Cochrane Database Syst Rev. 2022 Jul 18;7(7):CD008462. doi: 10.1002/14651858.CD008462.pub4. Cochrane Database Syst Rev. 2022. PMID: 35849083 Free PMC article. Review.
Our secondary outcomes were CVC-related bloodstream infections and CVC-related colonisation, mortality, haemorrhage, heparin-induced thrombocytopaenia, CVC-related thrombosis, number of additional CVC insertions, abnormality of coagulation profile and allergic reactions to …
Our secondary outcomes were CVC-related bloodstream infections and CVC-related colonisation, mortality, haemorrhage, heparin-induced thro …
1,849 results